MOLOGEN Competitors and Similar CompaniesClear all
KemPharm's competitors and similar companies include Immunocore.
 KemPharm KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. |  Immunocore Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases. | |
Founding Date | Founding Date 2006 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Kissimmee, US HQ Blacksburg, US Coralville, US Coralville, US | Locations Milton, GB HQ Conshohocken, US Rockville, US |
Employees | Employees 333% increase | Employees 493 |
Valuation ($) | Valuation ($) 200.5 m | Valuation ($) 1.6 b |
Financial | ||
Revenue (est.) | Revenue (est.) $106.5m (FY, 2025) | Revenue (est.) $400m (FY, 2025) |
Net income | Net income $83.2m (FY, 2025) | Net income ($35.5m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Immunocore
HQ
Milton, GB
Employees
493
Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases.
View company